Envoy Medical (COCH) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 13, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about COCH filings

Are insiders buying or selling Envoy Medical Inc. (COCH) stock?

Neither. Envoy Medical Inc. (COCH) insiders filed no open-market purchases or sales in the 90 days to Nov 13, 2026, according to SEC Form 4 filings.

Which members of Congress have traded COCH recently?

None. No member of Congress disclosed a COCH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this COCH smart-money data?

This summary uses filings available on Nov 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

4 funds hold a position.

Questions about COCH filings

Are insiders buying or selling Envoy Medical Inc. (COCH) stock?

Neither. Envoy Medical Inc. (COCH) insiders filed no open-market purchases or sales in the 90 days to Nov 13, 2026, according to SEC Form 4 filings.

Which members of Congress have traded COCH recently?

None. No member of Congress disclosed a COCH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this COCH smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 5, 2026

Earnings came in 28.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 5, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.50+28.57% beat

-$0.70 expected

Revenue

$66.0K

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 5, 2026	-$0.50est. -$0.70	+28.57%beat	$66.0KSEC filing	+57.1%from $42.0K
Jun 30, 2026Reported Aug 10, 2026	-$0.07est. -$0.09	+$0.02beat	$51.0KSEC filing	-34.6%from $78.0K
Mar 31, 2026Reported May 11, 2026	-$0.08est. -$0.14	+42.86%beat	$39.0KSEC filing	-15.2%from $46.0K
Dec 31, 2025Reported Mar 23, 2026	-$2.67Reported	No estimate	$241.0K · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 10, 2025	-$0.35est. -$0.29	-20.69%miss	$42.0KSEC filing	-25.0%from $56.0K
Jun 30, 2025Reported Jul 31, 2025	-$0.32est. -$0.29	-10.34%miss	$78.0KSEC filing	+14.7%from $68.0K
Mar 31, 2025Reported May 1, 2025	-$0.29est. -$0.20	-45.00%miss	$46.0KSEC filing	-22.0%from $59.0K
Dec 31, 2024Reported Mar 28, 2025	-$0.46est. -$0.31	-48.39%miss	$225.0K · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $7.01
High: $7.10
Low: $6.55
Prev close: $6.92
52-wk high: $9.54
52-wk low: $3.63
Mkt cap: $53.8M
ROE: +0.0%
Beta: 2.02
P/S: 260.0x
P/B: 14.9x
Profit margin: +0.0%
Op margin: -10920.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $54M

Valuation

P/S260.02
P/B14.90

Quality

Operating margin-10920.0%
ROE0.0%
ROA-86.5%

Growth

Beta2.02

Technicals

Price structure

This stock is in a strong uptrend, and looks overbought after a fast run-up.

Trend

Strong uptrend

85 / 100

RSI 14

76overbought

20D volatility

57%annualized

52-week range

$6.95

$3.63$9.54

20D support

$4.72recent floor

20D resistance

$7.46recent ceiling

Returns

5D -2.4%20D +9.1%60D -5.9%

Price vs moving averages

SMA20 +4.7%SMA50 +2.1%SMA200 +1.0%

Volume pace

1.31xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 5, 2026

-$0.50est. -$0.70

+28.57%

$66.0KSEC filing

+57.1%from $42.0K

Jun 30, 2026Aug 10, 2026

-$0.07est. -$0.09

+$0.02

$51.0KSEC filing

-34.6%from $78.0K

Mar 31, 2026May 11, 2026

-$0.08est. -$0.14

+42.86%

$39.0KSEC filing

-15.2%from $46.0K

Dec 31, 2025Mar 23, 2026

-$2.67Reported

No estimate

$241.0K · FYSEC filing

No year-ago quarter

Sep 30, 2025Nov 10, 2025

-$0.35est. -$0.29

-20.69%

$42.0KSEC filing

-25.0%from $56.0K

Jun 30, 2025Jul 31, 2025

-$0.32est. -$0.29

-10.34%

$78.0KSEC filing

+14.7%from $68.0K

Mar 31, 2025May 1, 2025

-$0.29est. -$0.20

-45.00%

$46.0KSEC filing

-22.0%from $59.0K

Dec 31, 2024Mar 28, 2025

-$0.46est. -$0.31

-48.39%

$225.0K · FYSEC filing

No year-ago quarter

Envoy Medical Inc.

Smart money at a glance

What do analysts expect?

Questions about COCH filings

Questions about COCH filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 28.6% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Envoy Medical Inc.

Smart money at a glance

What do analysts expect?

Questions about COCH filings

Questions about COCH filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 28.6% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Envoy Medical Inc.

Overview

Questions about COCH filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Envoy Medical Inc.

Overview

Questions about COCH filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.